Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 203

Sort by

Sort Order Select

Journal Articles

Clinical Efficacy of Ruxolitinib in Patients with Myelofibrosis: A Nationwide Population-Based Study in Korea

Byung-Hyun Lee, MD, Hyemi Moon, Ka-Won Kang, Byung Soo Kim, Yong Park

Blood (2019) 134 (Supplement_1): 2951.

https://doi.org/10.1182/blood-2019-122156

Published: 2019

Journal Articles

Megakaryocyte Ablation Ameliorates Bone Marrow Fibrosis By Reducing Myofibroblast Differentiation in a Mouse Model of Primary Myelofibrosis

Yutein Chung, PhD, Huiyan Jin, PhD, Claire Trasorras, Francina Gonzalez, Sang Hee Min, MD PhD

Blood (2019) 134 (Supplement_1): 2493.

https://doi.org/10.1182/blood-2019-132186

Published: 2019

Journal Articles

Atypical Chronic Myeloid Leukemia

Chandralekha Ashangari, MD, Praveen K. Tumula, MD

Blood (2018) 132 (Supplement 1): 5455.

https://doi.org/10.1182/blood-2018-99-110189

Published: 2018

Journal Articles

The Gef Domain of the BCR-FGFR1 Chimeric Kinase Attenuates SCLL Progression through the RhoA/Rock/Pten Signaling Axis

Tianxiang Hu, PhD, Yating Chong, MSc, Sumin Lu, PhD, John Kenneth Cowell, PhD DSc, FRCPath

Blood (2018) 132 (Supplement 1): 4325.

https://doi.org/10.1182/blood-2018-99-119204

Published: 2018

Journal Articles

Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience

Angelo Andreini, Nicola Zampieri, Claudio Costantini, Giovanni Malerba, Costanza Bruno, Gianluca Salvagno, Giuseppe Francia, Michele Gottardi, Michela Rimondini, Giuseppe Lippi, Isacco Ferrarini, Fabio Benedetti, Giovanni Pizzolo, Cristina Tecchio

Blood (2017) 130 (Supplement 1): 4530.

https://doi.org/10.1182/blood.V130.Suppl_1.4530.4530

Published: 2017

Journal Articles

Response to Ponatinib in Patients with Chronic Myeloid Leukaemia (CML), the Tawam (tertiary care referral hospital UAE) Experience

Arif Alam, MBBS, Jorgen Kristensen, MD PhD

Blood (2017) 130 (Supplement 1): 5262.

https://doi.org/10.1182/blood.V130.Suppl_1.5262.5262

Published: 2017

Journal Articles

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Matthew K Stein, MD, Dilan Patel, MD, Andrew Hahn, MD, Jamie Riney, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 1935.

https://doi.org/10.1182/blood.V128.22.1935.1935

Published: 2016

Journal Articles

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Paolo Bernasconi, MD, Irene Dambruoso, Marina Boni, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Marilena Caresana, Antonella Orlando, Ilaria Casetti, MD, Chiara Elena, MD, Elisa Rumi, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 5493.

https://doi.org/10.1182/blood.V128.22.5493.5493

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT

Blood (2015) 126 (23): 63.

https://doi.org/10.1182/blood.V126.23.63.63

Published: 2015

Journal Articles

Deep Molecular Response (DMR) in Chronic Myeloid Leukemia (CML) the Tawam Experience

Arif Alam, MBBS, Amar Lal, MD, Hani Y Osman, Sabir Hussain, MD, Donna Lee, Jorgen Kristensen, MD PhD

Blood (2015) 126 (23): 5152.

https://doi.org/10.1182/blood.V126.23.5152.5152

Published: 2015

Journal Articles

Depletion of Ptch2 Activates Canonical and Non-Canonical HH Signaling within the Niche Leading to Myeloproliferation, Stem Cell Exhaustion and Accelerates JAK2V617F Driven Disease

Claudius Klein, Anabel Kuhn, Sandra Kissel, Marie Follo, PhD, Anna Lena Illert, MD, Dietmar Pfeifer, Heike L Pahl, PhD, Robert A.J. Oostendorp, PhD, Justus Duyster, MD, Christine Dierks, MD

Blood (2015) 126 (23): 3593.

https://doi.org/10.1182/blood.V126.23.3593.3593

Published: 2015

Journal Articles

The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors

Ronit Yerushalmi, MD, Noga Shem-Tov, MD, Ivetta Danylesko, MD, Arnon Nagler, MD MSc, Avichai Shimoni, MD

Blood (2015) 126 (23): 1942.

https://doi.org/10.1182/blood.V126.23.1942.1942

Published: 2015

Journal Articles

Secondary Acute Myeloid Leukemia Is an Heterogeneous Subgroup of Elderly AML Where Patient’s Fitness Criteria and ELN Prognostic Stratification Can be Applied to Guide Treatment Decisions: An Analysis of 127 Patients By the Network Rete Ematologica Lombarda (REL)

Erika Borlenghi, MD, Chiara Pagani, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Matteo Carrabba, MD, Nicola Fracchiolla, MD, Francesca Guidotti, MD, Laura Marbello, MD, Andrea Ferrario, MD, Silvia Ferrari, MD, Francesca Schieppati, MD, Daniela Dalceggio, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 953.

https://doi.org/10.1182/blood.V124.21.953.953

Published: 2014

Journal Articles

Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?

Osman Ilhan, MD, Pinar Ataca, MD, Erden Atilla, MD, Selami Kocak Toprak, MD, Gulsah Kaygusuz, MD, Isinsu Kuzu, MD, Sinem Civriz Bozdag, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Meral Beksac, MD, Taner Demirer, MD, Hamdi Akan, MD, Nahide Konuk, MD, Gunhan Gurman, MD

Blood (2014) 124 (21): 5555.

https://doi.org/10.1182/blood.V124.21.5555.5555

Published: 2014

Journal Articles

IMPACT of Therapeutic Strategy and Time to Therapy Initiation on Clinical Evolution of Patients with NEWLY Diagnosed Chronic Myelomonocytic Leukemia. a Report from Erasme Study

Brayan Marcel Merchan Ruiz, Teresa Bernal, MD, Montserrat Arnan, MD, Mar Tormo, MD, Jose Angel Hernandez Rivas, Maria Calbacho, MDPhD, Rosa Coll, MD, Rafael Romero, Andres Insunza, MD, Joan Bargay, MD, David Valcarcel, MD PhD, Montse Rafel, Regina Garcia, MD

Blood (2014) 124 (21): 5607.

https://doi.org/10.1182/blood.V124.21.5607.5607

Published: 2014

Journal Articles

Fertility in Our Allogeneic Hematopoietic Stem Cell Transplant Patients

Pervin Topcuoglu, MD, Pinar Ataca, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Nahide Konuk, MD, Hamdi Akan, MD, Osman Ilhan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2014) 124 (21): 5887.

https://doi.org/10.1182/blood.V124.21.5887.5887

Published: 2014

Journal Articles

The Red Cell Mass (RCM) Value In Polycythaemia Vera Disease In The JAK2 V617F Era

Hassan A. Al-Jafar, MBChB , MD, Leena M Aytoglu, BSC-MSC(Master in molecular medecine), Issa Loutfi, Iman Al-Shemmari, Salem H Alshemmari, FRCPC

Blood (2013) 122 (21): 5249.

https://doi.org/10.1182/blood.V122.21.5249.5249

Published: 2013

Journal Articles

Evaluation Of The JAK2-V617F Gene Mutation In Egyptian Patients With Essential Thrombocythemia and Polycythemia Vera

Maha Ibrahim El Zaafarany, MD, A. Hasan Abdel-Ghaffar, Tawfik R. Elkhodary, MD, Dalia A. Salem, MD, Eman A. Soliman, MSc, Sameh S. Shamaa, MD

Blood (2013) 122 (21): 5254.

https://doi.org/10.1182/blood.V122.21.5254.5254

Published: 2013

Journal Articles

Defining The morphological Appearance Of ETV6-Abl Diseases. Evaluation Of a Case

Finella MC Brito-Babapulle, FRCPATH, Barbara Czepulkowski, BSc

Blood (2013) 122 (21): 5271.

https://doi.org/10.1182/blood.V122.21.5271.5271

Published: 2013

Journal Articles

Potent Cooperation Between NUP98-NSD1 and FLT3-ITD In AML Induction

Angeliki Thanasopoulou, PhD, Alexandar Tzankov, M.D., Juerg Schwaller, MD

Blood (2013) 122 (21): 3797.

https://doi.org/10.1182/blood.V122.21.3797.3797

Published: 2013

NARROW

Clinical Efficacy of Ruxolitinib in Patients with Myelofibrosis: A Nationwide Population-Based Study in Korea

Megakaryocyte Ablation Ameliorates Bone Marrow Fibrosis By Reducing Myofibroblast Differentiation in a Mouse Model of Primary Myelofibrosis

Atypical Chronic Myeloid Leukemia

The Gef Domain of the BCR-FGFR1 Chimeric Kinase Attenuates SCLL Progression through the RhoA/Rock/Pten Signaling Axis

Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience

Response to Ponatinib in Patients with Chronic Myeloid Leukaemia (CML), the Tawam (tertiary care referral hospital UAE) Experience

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT

Deep Molecular Response (DMR) in Chronic Myeloid Leukemia (CML) the Tawam Experience

Depletion of Ptch2 Activates Canonical and Non-Canonical HH Signaling within the Niche Leading to Myeloproliferation, Stem Cell Exhaustion and Accelerates JAK2V617F Driven Disease

The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors

Secondary Acute Myeloid Leukemia Is an Heterogeneous Subgroup of Elderly AML Where Patient’s Fitness Criteria and ELN Prognostic Stratification Can be Applied to Guide Treatment Decisions: An Analysis of 127 Patients By the Network Rete Ematologica Lombarda (REL)

Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?

IMPACT of Therapeutic Strategy and Time to Therapy Initiation on Clinical Evolution of Patients with NEWLY Diagnosed Chronic Myelomonocytic Leukemia. a Report from Erasme Study

Fertility in Our Allogeneic Hematopoietic Stem Cell Transplant Patients

The Red Cell Mass (RCM) Value In Polycythaemia Vera Disease In The JAK2 V617F Era

Evaluation Of The JAK2-V617F Gene Mutation In Egyptian Patients With Essential Thrombocythemia and Polycythemia Vera

Defining The morphological Appearance Of ETV6-Abl Diseases. Evaluation Of a Case

Potent Cooperation Between NUP98-NSD1 and FLT3-ITD In AML Induction

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only